Literature DB >> 3338181

Heterophilic antibodies: a problem for all immunoassays.

L M Boscato1, M C Stuart.   

Abstract

We verified that antibody-binding substances in serum that interfere in two-site immunoassays involving murine antibodies are heterophilic antibodies. Incubation of serum containing heterophilic antibodies and a murine monoclonal antibody to human choriogonadotropin (hCG) leads to formation of a series of soluble immune complexes. We investigated the recognition of hCG by reagent antibody in the presence of heterophilic antibodies and found this recognition to be diminished. Consequently, about 30% of serum samples containing heterophilic antibodies falsely appear to contain increased concentrations of hCG. The effect on analyte recognition probably results from steric inhibition of hCG binding to complexed antibody. Heterophilic antibodies detected with a murine antibody also bound immunoglobulin from several other species but did not bind all of those tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338181

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  28 in total

1.  Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum.

Authors:  Thomas B Martins; Brian M Pasi; Christine M Litwin; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum.

Authors:  I Sylvester; T Yoshimura; M Sticherling; J M Schröder; M Ceska; P Peichl; E J Leonard
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  The ELISA Standard Save: calculation of sample concentrations in assays with a failed standard curve.

Authors:  Sudha Natarajan; Daniel G Remick
Journal:  J Immunol Methods       Date:  2008-04-28       Impact factor: 2.303

4.  Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes.

Authors:  J X She; T M Ellis; S B Wilson; C H Wasserfall; M Marron; S Reimsneider; S C Kent; D A Hafler; D S Neuberg; A Muir; J L Strominger; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Interference in thyrotropin (TSH) determination: falsely elevated TSH values in a transplanted patient.

Authors:  J Seghers; F Schrurs; P De Nayer; C Beckers
Journal:  Eur J Nucl Med       Date:  1989

6.  Interferences in immunoassay.

Authors:  Jill Tate; Greg Ward
Journal:  Clin Biochem Rev       Date:  2004-05

7.  Assay interference leading to misdiagnosis of central precocious puberty.

Authors:  David G Segal; Linda A DiMeglio; Kenneth W Ryder; Pamela A Vollmer; Ora Hirsch Pescovitz
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

8.  False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.

Authors:  J Reinsberg; U Wagner; D Krebs
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

9.  Current concepts of thyroid function and laboratory evaluation.

Authors:  S Narayana
Journal:  Indian J Clin Biochem       Date:  1997-12

10.  Biochemical analysis of CTLA-4 immunoreactive material from human blood.

Authors:  Matt Tector; Bhupendra O Khatri; Karen Kozinski; Kate Dennert; Martin K Oaks
Journal:  BMC Immunol       Date:  2009-09-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.